Pheochromocytoma overview: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pheochromocytoma}} | {{Pheochromocytoma}} | ||
{{CMG}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
A '''pheochromocytoma''' ('''phaeochromocytoma''' outside of the US) is a [[neuroendocrine tumor]] of the [[Adrenal medulla|medulla]] of the [[adrenal gland]]s (originating in the [[chromaffin cell]]s) or extra-adrenal chromaffin tissue which failed to involute after birth,<ref>{{cite book |author=Boulpaep, Emile L.; Boron, Walter F. |title=Medical physiology: a cellular and molecular approach |publisher=Saunders |location=Philadelphia |year=2003 |pages=1065 |isbn=0-7216-3256-4 |oclc= |doi=}}</ref> which secretes excessive amounts of [[catecholamine]]s, usually [[epinephrine]] and [[norepinephrine]]. | A '''pheochromocytoma''' ('''phaeochromocytoma''' outside of the US) is a [[neuroendocrine tumor]] of the [[Adrenal medulla|medulla]] of the [[adrenal gland]]s (originating in the [[chromaffin cell]]s) or extra-adrenal chromaffin tissue which failed to involute after birth,<ref>{{cite book |author=Boulpaep, Emile L.; Boron, Walter F. |title=Medical physiology: a cellular and molecular approach |publisher=Saunders |location=Philadelphia |year=2003 |pages=1065 |isbn=0-7216-3256-4 |oclc= |doi=}}</ref> which secretes excessive amounts of [[catecholamine]]s, usually [[epinephrine]] and [[norepinephrine]]. | ||
| Line 8: | Line 8: | ||
==Historical Perspective== | ==Historical Perspective== | ||
In 1886, Fränkel made the first description of a patient with pheochromocytoma, however the term was first coined by Pick, a pathologist, in 1912. In 1926, Roux (in Switzerland) and Mayo (in U.S.A.) were the first surgeons to remove pheochromocytomas.<br /> | In 1886, Fränkel made the first description of a patient with pheochromocytoma, however the term was first coined by Pick, a pathologist, in 1912. In 1926, Roux (in Switzerland) and Mayo (in U.S.A.) were the first surgeons to remove pheochromocytomas.<br /> | ||
==Pathophysiology== | |||
On gross pathology pheochromocytoma appears as Multinodular, multicentric pattern of growth. On microscopic histopathological analysis nesting (Zellballen) pattern composed of well-defined clusters of tumour cells separated by fibrovascular stroma is a characteristic finding. | |||
==Classification== | |||
Pheochromocytoma can be either [[benign]] or [[malignant]] and can be localized, regional or [[metastatic]]. | |||
==Causes== | |||
Familial pheochromocytoma may be caused by either mutation of ''[[VHL]]'', ''RET'', ''NF1'', ''[[SDHB]]'' and ''[[SDHD]]'' genes. | |||
==Differentiating Pheochromocytoma from other Diseases== | |||
Pheochromocytoma must be differentiated from [[anxiety]], [[carcinoid]], and [[hypoglycemia]]. | |||
==Epidemiology and Demographics== | |||
The [[incidence]] of pheochromocytoma ranges from a low of 0.2 per 100,000 persons to a high of 0.8 per 100,000 persons. The average age at diagnosis is 24.9 years in hereditary cases and 43.9 years in sporadic cases with men and women equally affected.<ref name="cancergov"> National Cancer Institute. Physician Data Query Database 2015. National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq#link/_25_toc</ref> | |||
==Natural History, Complication and Prognosis== | |||
Prognosis of pheochromocytoma is generally good but metastatic pheochromocytoma has a 5 year survival rate of approximately 45%.<ref name="cancergov"> National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq#link/_25_toc</ref> Massive release of [[catecholamines]] can causes damage to myocytes. | |||
==Diagnosis== | |||
===Symptoms=== | |||
Symptoms of pheochromocytoma include [[palpitations]], [[anxiety]], and [[headaches]]. | |||
===Physical Examination=== | |||
Common physical exam findings of pheochromocytoma include [[palpitation]], [[hypertension]], and [[orthostatic hypotension]]. | |||
===Laboratory Findings=== | |||
Laboratory findings consistent with the diagnosis of pheochromocytoma include elevated [[catecholamines]] and [[metanephrine]] levels. | |||
===CT=== | |||
[[Head]], [[neck]], [[chest]], and [[abdomen]] CT scans may be helpful in the diagnosis of pheochromocytoma. | |||
===MRI=== | |||
[[Head]], [[neck]], [[chest]], and [[abdomen]] MRI may be helpful in the diagnosis of pheochromocytoma. | |||
===Other Imaging Findings=== | |||
<sup>123</sup>I-metaiodobenzylguanidine (MIBG) scintigraphy coupled with CT imaging can be used for diagnosis of pheochromocytoma. | |||
===Other Diagnostic Studies=== | |||
[[Clonidine#Clonidine suppression test|Clonidine suppression test]] may be used in the diagnosis of pheochromocytoma. | |||
==Treatment== | |||
===Medical Therapy=== | |||
The predominant therapy for pheochromocytoma is surgical resection. Treatment with [[alpha blockers]] (example: [[phenoxybenzamine]]) followed by [[beta blockers]] (example: [[atenolol]]) is required before surgery. Adjunctive chemotherapy and radiation are used in metastatic disease. | |||
===Surgery=== | |||
Surgery is the mainstay of treatment for pheochromocytoma. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 20:59, 2 September 2015
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma overview On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma overview |
|
Risk calculators and risk factors for Pheochromocytoma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
A pheochromocytoma (phaeochromocytoma outside of the US) is a neuroendocrine tumor of the medulla of the adrenal glands (originating in the chromaffin cells) or extra-adrenal chromaffin tissue which failed to involute after birth,[1] which secretes excessive amounts of catecholamines, usually epinephrine and norepinephrine. Extra-adrenal paragangliomas (often described as extra-adrenal pheochromocytomas) are closely related, though less common, tumors that originate in the ganglia of the sympathetic nervous system and are named based upon the primary anatomical site of origin.
Historical Perspective
In 1886, Fränkel made the first description of a patient with pheochromocytoma, however the term was first coined by Pick, a pathologist, in 1912. In 1926, Roux (in Switzerland) and Mayo (in U.S.A.) were the first surgeons to remove pheochromocytomas.
Pathophysiology
On gross pathology pheochromocytoma appears as Multinodular, multicentric pattern of growth. On microscopic histopathological analysis nesting (Zellballen) pattern composed of well-defined clusters of tumour cells separated by fibrovascular stroma is a characteristic finding.
Classification
Pheochromocytoma can be either benign or malignant and can be localized, regional or metastatic.
Causes
Familial pheochromocytoma may be caused by either mutation of VHL, RET, NF1, SDHB and SDHD genes.
Differentiating Pheochromocytoma from other Diseases
Pheochromocytoma must be differentiated from anxiety, carcinoid, and hypoglycemia.
Epidemiology and Demographics
The incidence of pheochromocytoma ranges from a low of 0.2 per 100,000 persons to a high of 0.8 per 100,000 persons. The average age at diagnosis is 24.9 years in hereditary cases and 43.9 years in sporadic cases with men and women equally affected.[2]
Natural History, Complication and Prognosis
Prognosis of pheochromocytoma is generally good but metastatic pheochromocytoma has a 5 year survival rate of approximately 45%.[2] Massive release of catecholamines can causes damage to myocytes.
Diagnosis
Symptoms
Symptoms of pheochromocytoma include palpitations, anxiety, and headaches.
Physical Examination
Common physical exam findings of pheochromocytoma include palpitation, hypertension, and orthostatic hypotension.
Laboratory Findings
Laboratory findings consistent with the diagnosis of pheochromocytoma include elevated catecholamines and metanephrine levels.
CT
Head, neck, chest, and abdomen CT scans may be helpful in the diagnosis of pheochromocytoma.
MRI
Head, neck, chest, and abdomen MRI may be helpful in the diagnosis of pheochromocytoma.
Other Imaging Findings
123I-metaiodobenzylguanidine (MIBG) scintigraphy coupled with CT imaging can be used for diagnosis of pheochromocytoma.
Other Diagnostic Studies
Clonidine suppression test may be used in the diagnosis of pheochromocytoma.
Treatment
Medical Therapy
The predominant therapy for pheochromocytoma is surgical resection. Treatment with alpha blockers (example: phenoxybenzamine) followed by beta blockers (example: atenolol) is required before surgery. Adjunctive chemotherapy and radiation are used in metastatic disease.
Surgery
Surgery is the mainstay of treatment for pheochromocytoma.
References
- ↑ Boulpaep, Emile L.; Boron, Walter F. (2003). Medical physiology: a cellular and molecular approach. Philadelphia: Saunders. p. 1065. ISBN 0-7216-3256-4.
- ↑ 2.0 2.1 National Cancer Institute. Physician Data Query Database 2015. National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq#link/_25_toc